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Abstract
Angiotensin II (AngII) acts on central neurons to increase neuronal firing and
induce sympathoexcitation, which contribute to the pathogenesis of cardiovascular diseases including hypertension and heart failure. Numerous studies
have examined the precise AngII-induced intraneuronal signaling mechanism
in an attempt to identify new therapeutic targets for these diseases. Considering the technical challenges in studying specific intraneuronal signaling pathways in vivo, especially in the cardiovascular control brain regions, most
studies have relied on neuronal cell culture models. However, there are
numerous limitations in using cell culture models to study AngII intraneuronal signaling, including the lack of evidence indicating the stability of AngII
in culture media. Herein, we tested the hypothesis that exogenous AngII is
rapidly metabolized in neuronal cell culture media. Using liquid chromatography-tandem mass spectrometry, we measured levels of AngII and its metabolites, Ang III, Ang IV, and Ang-1-7, in neuronal cell culture media after
administration of exogenous AngII (100 nmol/L) to a neuronal cell culture
model (CATH.a neurons). AngII levels rapidly declined in the media, returning to near baseline levels within 3 h of administration. Additionally, levels of
Ang III and Ang-1-7 acutely increased, while levels of Ang IV remained
unchanged. Replenishing the media with exogenous AngII every 3 h for 24 h
resulted in a consistent and significant increase in AngII levels for the duration of the treatment period. These data indicate that AngII is rapidly metabolized in neuronal cell culture media, and replenishing the media at least every
3 h is needed to sustain chronically elevated levels.
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Introduction
Dysregulation of angiotensin II (AngII)-dependent neuronal signaling in the central nervous system is involved in
the pathogenesis of cardiovascular diseases, such as hypertension and chronic heart failure (Phillips and Sumners
1998; Veerasingham and Raizada 2003; Guyenet 2006;

Zucker 2006). Activation of the renin–angiotensin system
and elevated levels of AngII in the brain are associated
with the development and maintenance of various forms
of experimental and genetic models of hypertension
(Basso et al. 1981; Ganten et al. 1983; Davisson et al.
1998; Morimoto et al. 2001). By acting on specific brain
regions that are important in autonomic control of
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cardiovascular function, including the subfornical organ
(SFO), paraventricular nucleus (PVN), and rostral ventrolateral medulla (RVLM), AngII increases neuronal firing
leading to the deleterious sympathoexcitation commonly
associated with neurocardiovascular diseases (Bains et al.
1992; Ferguson and Bains 1997; Gao et al. 2005; Feng
et al. 2008). In addition, AngII stimulation of its type I
receptor (AT1R) in these cardiovascular control brain
regions and others contributes to vasopressin secretion,
thirst and salt appetite, and baroreflex modulation (Matsukawa et al. 1991; Reid 1992; Johnson and Thunhorst
1997). AngII can also activate its type 2 receptor (AT2R)
on central neurons, which often results in opposing
responses compared to AT1R activation, reflecting the different physiological and pathophysiological roles of AngII
mediated via these receptors (Sumners et al. 1994).
Considering the importance of AngII intraneuronal
signaling in the pathogenesis of neurocardiovascular diseases, including hypertension and heart failure, numerous studies have been devoted to better understand the
precise signaling pathways involved in an attempt to
identify new therapeutic targets for these diseases. However, there are significant technical challenges in studying
AngII-induced intraneuronal signaling in vivo in animal
models of hypertension and heart failure such as: (1)
limited number of neurons within a specific cardiovascular control brain region of interest to perform a particular assay; (2) separating intraneuronal signaling events
from other pathways activated in neighboring cells
including glia and endothelial cells; and (3) separating
the signaling mechanisms of other peptides and hormones associated with these diseases from those directly
induced by AngII. To circumvent these challenges, neuronal cell culture models have been frequently utilized to
examine the specific intraneuronal signaling pathways
induced by AngII. Such studies have clearly identified
important roles for calcium, reactive oxygen species, kinases, and transcription factors in the AngII intraneuronal
signaling pathway (Sun et al. 2003; Zimmerman et al.
2004, 2005; Haack et al. 2013).
Nevertheless, there are also limitations in using neuronal cell culture models to recapitulate the AngII intraneuronal signaling events occurring in vivo such as: (1)
neuronal cells are often immortalized and/or isolated
from a tumor; (2) cells are usually cultured in a hyperoxic environment (i.e., 21% oxygen) as compared to their
in vivo environment (1–4% oxygen); and (3) the lack of
neighboring glia and endothelial cells may alter a particular response in the cultured neurons that would normally
occur in vivo. A fourth limitation in using neuronal cell
culture models as it specifically relates to understanding
AngII intraneuronal signaling is the lack of evidence
indicating the stability of exogenous AngII in neuronal
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cell culture media. Many studies have examined intraneuronal responses, such as changes in mRNA levels and
protein expression, 1–48 h after a single administration of
exogenous AngII into the neuronal cell culture media
(Liu et al. 2006; Mitra et al. 2010; Xia et al. 2011). Data
from these studies are often interpreted to indicate that
the observed changes are also occurring in neurons of
various hypertensive and heart failure models in which
circulating and/or brain levels of AngII are chronically
elevated (van de Wal et al. 2006; Xia et al. 2013). However, it remains unclear if a single treatment of exogenous
AngII given to neurons in culture results in a chronic elevation of AngII levels in the media.
In the current study, we tested the hypothesis that exogenous AngII is rapidly metabolized in neuronal cell culture
medium and thus fails to remain chronically elevated following a single exogenous administration. We utilized a
mouse catecholaminergic neuronal cell line, CATH.a neurons, which express both AT1R and AT2R. CATH.a neurons have commonly been used by our group and others
to study AngII intraneuronal signaling pathways (Sun
et al. 2003; Gao et al. 2010; Case et al. 2013). Previous
studies have shown that deletion of the AT1R from
catecholaminergic neurons delays the onset of AngIIdependent hypertension and also reduces the maximal
blood pressure response (Jancovski et al. 2013). In
addition, catecholaminergic neurons, such as C1 neurons
in the RVLM, play an important role in AngII-induced
hypertension and blocking the AT1R specifically in these
neurons can attenuate the AngII-mediated rise in blood
pressure (Jancovski et al. 2014). Using liquid chromatography-tandem mass spectrometry, we measured levels of
AngII and its metabolites, Ang III, Ang IV, and Ang-1-7, in
CATH.a neuronal cell culture media after administration of
exogenous AngII. Herein, we report that exogenous AngII
is rapidly metabolized in CATH.a neuron media with levels
returning to near baseline after 3 h of administration.
Further, AngII levels in CATH.a neuron media can be
significantly and chronically elevated for at least 24 h with
the addition of fresh exogenous AngII every 3 h.

Materials and Methods
Neuronal cell culture
Mouse catecholaminergic CATH.a neurons (American
Type Culture Collection (ATCC), stock no. CRL–11179)
were cultured in RPMI 1640 medium supplemented with
8% normal horse serum (NHS), 4% fetal bovine serum,
and 1% penicillin-streptomycin at 37°C with 5% CO2
as recommended by ATCC. CATH.a neurons were differentiated for 6–8 days before experimentation by adding
N6,20 -O-dibutyryladenosine 30 ,50 - cyclic monophosphate
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sodium salt (1 mmol/L, Sigma-Aldrich, St. Louis, MO) to
the culture medium as previously described (Case et al.
2013).

Liquid chromatography – tandem mass
spectrometry (LC-MS/MS)
CATH.a neuronal culture medium was collected after
incubation (15 min – 24 h) with AngII (100 nmol/L).
The 13C- and 15N-labeled (Leu, + 7 amu) AngII (H-AngII,
Anaspec, Fremont, CA) was added to the media samples
at a concentration of 18.2 nmol/L. Proteins were precipitated by addition of 6 volumes of cold neat acetone,
typically 50 lL of sample and 300 lL of acetone and
stored at 35°C for 1 h. Then, the samples were centrifuged at 4°C for 15 min at 15,000 9 g. Thereafter, the
supernatants were removed and the acetone/water was
removed by SpeedVac concentration for 2–3 h at room
temperature. The pellet was redissolved into 50 lL of
0.1% formic acid vortexed and centrifuged. The samples
were loaded onto V-shaped polyethylene vials (Agilent,
Santa Clara, CA) that were previously soaked with 0.1%
w/v BSA and dried. The LC-MS/MS method was developed and used for the samples using an Agilent LC1200
HPLC system (Agilent) connected to an ABSciex
QTrap4000 (ABSciex, Framingham, MA) operating in the
multiple reaction monitoring (MRM) mode with the electrospray operating in the positive mode. Other ion-source
conditions were temperature, 500°C, ionization potential,
5500 V, GS1 = 50, GS2 = 25, curtain gas = 30. The transitions monitored and ionization parameters are shown in
Table 1. Transitions numbered 1,3,5,8 and 9 were used
for quantitation while the remaining ones were used for
confirmation of peak assignment. Column chromatography was performed via a 2.1 9 50 mm Kinetex C-18 300

A (Phenomenex, Torrance, CA) at a flow rate of 250 lL/
min with a mobile phase gradient from 98% A (0.1% formic acid in LC-water) to 98% B (0.1% formic acid in

acetonitrile) over 20 min, with additional holding at 98%
B for 2 min and re-equilibration at 98% A for 10 min.
Transitions were monitored with an acquisition time of
100 msec/MRM in the nonscheduled mode. The data
were analyzed using Analyst Ver 1.4.2. AngII levels were
quantified using H-AngII as a standard. The other angiotensin peptides (Ang III, Ang IV, and Ang-1-7) were
quantified by comparison to an external calibration curve
of the unlabeled commercially available peptides, and
H-AngII was used as a surrogate to correct for concentration
loss of the peptides during sample preparation. The
recoveries of the spiked H-AngII were equal to or higher
than 80% for the analytical method. Individual samples
were injected in triplicate and the average angiotensin
peptide concentrations and standard error are reported.
All reagents used for LC-MS/MS analysis were of Mass
Spectrometry Grade and all unlabeled angiotensin peptide
standards and reagents were purchased from SigmaAldrich (St. Louis, MO).

Statistical analysis
All data are expressed as the mean  standard error of
the mean (SEM) and were analyzed by Student’s t-test for
two-group comparisons or by ANOVA followed by Newman–Keuls correction for multiple comparisons. Statistical analyses were performed using GraphPad Prism 5.0
(La Jolla, CA) statistical and graphical software. Differences were considered significant at P < 0.05.

Results
Utilizing liquid chromatography – tandem
mass spectrometry to detect angiotensin
peptides
AngII is generated from angiotensin-converting enzyme
(ACE) cleaving angiotensin I, which is produced by

Table 1. Instrument parameters for multiple reaction monitoring (MRM).
Transition number

Peptide

Q1 (m/z)

Q3 (m/z)

Declustering potential, V

Collision energy, V

1
2
3
4
5
6
7
8
9
10

AngII
AngII
H-AngII
H-AngII
AngIII
AngIII
AngIV
AngIV
Ang1-7
Ang1-7

349.6
524
352
527.5
311.3
311.3
388.3
388.3
301
301

255.2
784.1
255.2
791.1
256
514
513.6
263.4
371
344

40
60
40
60
40
30
50
45
40
30

30
30
30
30
15
12
15
20
15
15

Transitions 1, 3, 5, 8, and 9 were used for quantitation while transitions 2, 4, 6, 7, and 10 are for confirming peak assignments.
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renin-induced cleavage of angiotensinogen. Although
AngII is considered to be the primary effector peptide
of the renin–angiotensin system, AngII can be further
metabolized to other angiotensin peptides which have
been shown to contribute to cardiovascular function
(Campagnole-Santos et al. 1989; Santos et al. 2000; Wilson 2005; Ruiz-Ortega et al. 2007; Marc et al. 2012;
Gao et al. 2014). For example, AngII can be cleaved by
angiotensin-converting enzyme 2 (ACE2) to form Ang1-7 or by aminopeptidase A to form Ang III, which is
further metabolized by aminopeptidase N to form Ang
IV (Fig. 1). Although the primary objective of this
study was to examine the stability of exogenous AngII
in neuronal cell culture media, it was also important to
determine if exogenous AngII is metabolized to these
other angiotensin peptides. As shown in the representative chromatogram (Fig. 2), we were able to successfully
separate and detect all four angiotensin peptides from a
mixture containing the commercially available peptides
ranging in concentration from 12–16 nmol/L. AngII is
an octapeptide which under the conditions of the chromatography should accumulate in the +3 charged state
due to the positive charges at the terminal amino
group as well as the Arg and His side chains. Upon
loss of the C-terminus Phe, rendering Ang-1-7, the
peptide is much less hydrophobic and thus binds less
strongly to the C-18 side chains of the HPLC column
particles. Since Phe is more hydrophobic than Asp,
removal of Asp instead of Phe from AngII makes the
Ang III peptide less hydrophobic than AngII but more
than Ang-1-7. Therefore, Ang III elutes between Ang-1-

Figure 1. Schematic of the renin–angiotensin system. AngII is
generated by angiotensin-converting enzyme (ACE)-induced
cleavage of angiotensin I. AngII is subsequently metabolized to Ang
III and Ang-1-7 peptide via aminopeptidase A and angiotensinconverting enzyme 2 (ACE2), respectively. Ang III is further
metabolized by aminopeptidase N to generate Ang IV.
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7 and AngII (Fig. 2). The hexapeptide Ang IV is generated from the removal of the N-terminus positive side
chain Arg from Ang III, while keeping the hydrophobic
residues Ile and Phe. As a result of Ang IV being the
most hydrophobic, it has the strongest binding and
thus appears as the last peak in the chromatogram
(Fig. 2). To accurately quantify the concentration of
these peptides in our subsequent studies using media
samples from the CATH.a neuronal culture, we utilized
13
C- and 15N-labeled AngII (H-AngII).

Exogenous AngII is rapidly metabolized in
CATH.a neuronal cell culture media
Levels of AngII, Ang III, Ang IV, and Ang-1-7, were
measured in CATH.a neuronal cell culture media
15 min – 24 h after a single administration of exogenous AngII (100 nmol/L) into the media. As expected,
AngII was significantly elevated in the media 15 min
after administration as compared to media collected
immediately prior to treatment (Fig. 3A). Levels of
AngII rapidly decreased over time until 3 h-postadministration when levels of AngII in the media were
significantly lower compared to the 15 min time-point
and not significantly different than baseline levels. AngII
remained low, that is, it was undetectable 6 and 24 h
after administration. Interestingly, levels of Ang III
(Fig. 3B) and Ang-1-7 (Fig. 3D) modestly, but significantly, increased 15–60 min after exogenous AngII
administration. In contrast, levels of Ang IV remained
unchanged compared to baseline levels (Fig. 3C). It
should be noted that we specifically selected the AngII
concentration of 100 nmol/L for these studies because
we wanted to replicate, as best we could, the
experimental conditions used in other published studies
designed to examine the AngII-induced acute and
chronic responses in cultured neurons. For example, we
previously used 100 nmol/L AngII to study AngII-mediated intraneuronal signaling in CATH.a neurons and
have shown that at this concentration AngII-induced
Nox4-generated mitochondrial superoxide production
contributes to the rapid inhibition of outward K+
current (Yin et al. 2010; Case et al. 2013). Furthermore,
Sun et al., have reported that 100 nmol/L AngII rapidly
inhibits the delayed rectifier K+ current and increases
neuronal firing rate in primary neurons isolated from
the brain (Sun et al. 2002, 2003). Additional studies
examining more long-term changes (i.e., hours to days)
in the expression of various proteins, including AngII
receptors, potassium channels, and transcription factors,
also used 100 nmol/L AngII (Gao et al. 2010; Mitra
et al. 2010; Haack et al. 2012, 2013).

ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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Figure 2. Angiotensin peptides detected by liquid chromatography-tandem mass spectrometry. Representative chromatogram showing the
detection of individual angiotensin peptides (AngII, Ang III, Ang IV, and Ang-1-7) in a mixture of the commercially available peptides in a
concentration ranging from 12–16 nmol/L. 13C- and 15N-labeled AngII (H-AngII) was also added to the mixture and used to quantify absolute
amounts of the angiotensin peptides in the CATH.a neuronal cell culture media samples analyzed in subsequent experiments.

A

B

C

D

Figure 3. Exogenous AngII levels rapidly decrease within 3 h in CATH.a neuronal cell culture media. Levels of AngII (A), Ang III (B), Ang IV (C),
and Ang-1-7 (D) in CATH.a neuronal cell culture media following a single administration of exogenous AngII (100 nmol/L) as measured by
liquid chromatography-tandem mass spectrometry. Absolute concentrations were calculated against the standard 13C- and 15N-labeled AngII
peptide. n = 3 separate experiments performed in triplicate. *P < 0.05 vs. 0min AngII; #P < 0.05 vs. 15 min AngII.

Exogenous AngII is stable in neuronal cell
culture media in the absence of CATH.a
neurons
The rapid decrease in exogenous AngII levels in media
collected from CATH.a neurons may suggest that the

peptide is degraded by the media itself. To examine this
possibility, AngII (100 nmol/L) was added to the media
in the absence of CATH.a neurons and samples were collected 15 min – 24 h later (Fig. 4). AngII levels remained
significantly elevated at all time-points with concentrations near the starting concentration of 100 nmol/L

ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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A

B

C

D

Figure 4. AngII is stable in neuronal cell culture media in the absence of CATH.a neurons. Levels of AngII (A), Ang III (B), Ang IV (C), and Ang1-7 (D) in cell culture media without CATH.a neurons following a single administration of exogenous AngII (100 nmol/L) as detected by liquid
chromatography and tandem mass spectrometry. Absolute concentrations were calculated against the standard 13C- and 15N-labeled AngII
peptide. n = 3 separate experiments performed in triplicate. *P < 0.05 vs. 0 min.

(Fig. 4A). In contrast, levels of Ang III, Ang IV, and Ang1-7 were not significantly different than baseline levels
(Fig. 4B–D).

Replenishing CATH.a neuronal cell culture
media every 3 h with fresh exogenous AngII
results in chronic elevated levels

pathophysiological responses of AngII (Sumners et al.
2002; Zimmerman 2011; Chan and Chan 2013). Many of
these studies have relied on neuronal cell culture models
to demonstrate a role for signaling intermediates, such as
calcium, reactive oxygen species, kinases, and transcription factors in mediating the AngII-induced response
(Sun et al. 2003; Zimmerman et al. 2004, 2005; Haack

Finally, to determine if levels of AngII could be chronically elevated in CATH.a neuronal cell culture media, we
administered fresh exogenous AngII (100 nmol/L) every
3 h and measured AngII for up to 24 h. As shown in
Fig. 5, AngII levels remained similarly and significantly
elevated (63–72 nmol/L) at each time-point compared to
baseline levels.

Discussion
The pathogenesis of various cardiovascular disorders, such
as hypertension and chronic heart failure, involves dysregulation of the brain angiotensinergic system (Phillips
and Sumners 1998; Veerasingham and Raizada 2003;
Zucker 2006). Understanding the precise intraneuronal
signaling mechanism(s) driving this dysregulation may
lead to the identification of new targets for which novel
therapeutics can be developed. As such, numerous studies
have focused on examining the intraneuronal signaling
molecules and proteins mediating the physiological and

2015 | Vol. 3 | Iss. 2 | e12287
Page 6

Figure 5. Repeated administration of exogenous AngII every 3 h
maintains a chronic elevated level of AngII in CATH.a neuronal cell
culture media. Levels of AngII in CATH.a neuronal cell culture
media following repeated administration of exogenous AngII
(100 nmol/L) into the media every 3 h for 6, 9, 12, 15, 21, and
24 h. Absolute concentrations were calculated against the standard
13
C- and 15N-labeled AngII peptide. n = 3 separate experiments
performed in triplicate. *P < 0.05 vs. 0 min.
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et al. 2013). However, relating these in vitro observations
to in vivo AngII-dependent cardiovascular diseases, such
as hypertension and chronic heart failure, where circulating and central levels of AngII are chronically elevated
(van de Wal et al. 2006; Xia et al. 2013) is problematic as
the stability of exogenously administered AngII in neuronal cell culture media is unknown. In the current study,
we examined the stability of exogenous AngII in the culture media of an AngII-sensitive neuronal cell culture
model, CATH.a neurons, that has commonly been utilized to study AngII intraneuronal signaling (Sun et al.
2003; Gao et al. 2010; Case et al. 2013). Herein, we report
that levels of exogenous AngII are diminished to near
baseline levels within 3 h of treatment, and that media
should be replenished with fresh AngII every 3 h to
maintain chronically elevated levels of the peptide in this
neuronal cell culture model.
Acute stimulation (i.e., minutes) of cultured neurons
with AngII results in a rapid increase in intracellular calcium (Zimmerman et al. 2005), inhibition of outward
potassium current (IKv) (Sun et al. 2003; Yin et al. 2010),
and an increase in neuronal firing (Sun et al. 2002).
Chronic stimulation (i.e., hours to days) of AngII-sensitive cultured neurons leads to alterations in the expression of angiotensin receptors (Liu et al. 2006; Xia et al.
2011), potassium channel proteins (Gao et al. 2010), and
transcription factors (Mitra et al. 2010). However, in
most, if not all, of these chronic stimulation studies, a
single administration of exogenous AngII was given to
neurons in culture. This begs the questions of whether
AngII remains stable in the culture media for hours or
days to continuously activate its receptors to mediate
these changes in protein expression or if these changes
are a result of the immediate stimulation of AngII receptors followed by prolonged intraneuronal signaling events.
With these questions unanswered, it is difficult to compare results obtained from these types of in vitro studies
with data obtained from in vivo cardiovascular disease
models in which AngII receptors are likely constantly activated due to the chronically elevated levels of AngII. Our
new data presented herein indicates that levels of exogenously administered AngII in neuronal cell culture media
are decreased to near baseline levels within 3 h; thus, suggesting that changes in protein expression at later time
points are due to prolonged intraneuronal signaling
events rather than continuous activation of AngII receptors. In fact, we observed that within 15 min of treating
cells with 100 nmol/L AngII only 53  4 nmol/L AngII
remained in the media, and by 3 h post-treatment, less
than 5 nmol/L AngII remained. As we report, some of
the exogenous AngII is metabolized in the media
to Ang III and Ang-1-7, as the concentration of these
two peptides increased 15 min after AngII treatment.

Exogenous AngII Stability in Neuron Culture Media

We speculate that most of the AngII lost within the first
15 min of treatment is bound to the AngII receptors and
internalized via receptor-mediated endocytosis. In support
of this hypothesis, previous studies using aortic smooth
muscle cells have demonstrated that after AngII binds to
its receptor, the complex is internalized with a half-time
of less than 2 min (Anderson et al. 1993). In addition,
previous reports indicate a functional role for internalized
AngII after it has bound to the AT1R and the complex
has been endocytosed (Harris 1999). For example, the
complete AT1R-induced activation of mitogen-activated
protein kinase (MAPK) is believed to be dependent on
internalization (Yang et al. 1997). Furthermore, nuclear
membrane-associated angiotensin receptors have been
identified (Pendergrass et al. 2006; Gwathmey et al. 2009)
and may be stimulated by internalized AngII and/or by
AngII generated via an intracellular renin–angiotensin
system (Grobe et al. 2008).
After observing the rapid decrease in exogenously
administered AngII in the media of our neuronal cell culture model, we questioned whether this was cell-mediated
or nonspecific degradation of AngII in the media. To
address this question, we measured levels of AngII in culture media in the absence of CATH.a neurons after a single exogenous administration of 100 nmol/L AngII, and
found that AngII is relatively stable in the media. More
specifically, the concentration of AngII at all time-points
measured (15 min – 24 h) was approximately 80 nmol/L
or greater. Taken together with our results in the presence
of CATH.a neurons, these data suggest that the rapid loss
of exogenous AngII in the media of CATH.a neurons is
mostly cell-dependent with the AngII being metabolized
to Ang III and Ang-1-7, or binding to its receptors, along
with some nonspecific degradation of the peptide. As
such, it is likely that the stability of exogenous AngII in
cultured media will be drastically different between various cells types. That is, the expression levels of aminopeptidase A, which cleaves AngII to Ang III, ACE2, which
cleaves AngII to Ang-1-7, and/or AngII receptors in a
particular cell type will influence the stability of exogenous AngII in the respective media. Although we did not
observe a change in Ang IV in the current study with
CATH.a neurons, it is tempting to speculate that the
amount of aminopeptidase N, which cleaves Ang III to
Ang IV, expressed by a particular cell line will also contribute to the levels of these angiotensin peptides in culture media. Furthermore, it is possible that the stability of
AngII in culture media may be experimentally manipulated by the exogenous administration of aminopeptidase
inhibitors, ACE2 inhibitors, and/or AngII receptor antagonists.
In conclusion, our results demonstrate that a single
exogenous administration of AngII to CATH.a neurons
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in culture does not result in chronically elevated levels
of AngII in the media. As such, we sought to determine
if multiple and sequential administration would keep
AngII levels elevated chronically. Our data show that
giving fresh AngII (100 nmol/L) every 3 h to cultured
CATH.a neurons does indeed keep levels of AngII in the
media significantly elevated for at least 24 h. We believe
cell culture models with chronically elevated levels of
AngII are the ideal in vitro models that one should utilize to study the precise AngII-dependent intracellular
signaling events that occur in cardiovascular diseases
associated with systemic and/or local chronically elevated
levels of AngII, including hypertension and chronic heart
failure. We posit that keeping levels of AngII chronically
elevated in cell culture models will change the cellular
response induced by AngII compared to the response
induced by a single administration. Alternatively, it is
possible that AngII levels may not need to be chronically
elevated in cell culture media to induce long-term effects
as the initial stimulation of AngII receptors may activate
intracellular signaling pathways that lead to chronic
changes in the expression of AngII receptors, ion channel proteins, and transcription factors. To address these
hypotheses, our laboratory is currently investigating
changes in AngII-dependent intracellular signaling events
in CATH.a neurons exposed to single versus repeated
administration of AngII. More specifically, we are examining changes in AngII receptor expression, levels of
reactive oxygen species and antioxidants, intracellular
calcium concentration, activation of transcription factors,
and expression of ion channels. Importantly, we are
comparing any changes in response to single or repeated
administration of AngII to those that we observe in cardiovascular control brain nuclei (e.g. SFO, PVN, RVLM)
collected from animal models in which AngII is known
to be chronically elevated in the brain, including hypertensive and chronic heart failure models. We believe
these, and other, future studies will provide further
insight into the importance of establishing cell culture
models with chronically elevated levels of AngII to
improve our understanding of AngII intracellular signaling pathways.
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